Follow The Filings

ROIV Roivant Sciences

Roivant Sciences earnings company data as of 12:05 PM ET 11/17

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2027 Q2 9 Nov EPS -0.45 -0.27 Beat
Rev $4.1M — —

Insider trades

Open-market buys and sales by ROIV's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ROIV insider trades
  • None no insider bought on the open market
  • $779M sold by 10 insiders outside a trading plan
  • $174M sold by 4 insiders under 10b5-1 plans
  1. Keith S. Manchester Director
    Sale
    $53.5M 1,381,762 shares at $38.75 19% of stake
    Traded Nov 16–17 Filed Nov 18
  2. Richard Pulik CFO
    Sale
    $12.5M 300,000 shares at $41.58 58% of stake
    Traded Nov 10–11 Filed Nov 12
  3. Eric Venker CEO
    Planned sale
    $7.6M 187,943 shares at $40.53 19% of stake
    Traded Nov 10 Filed Nov 12
  4. Eric Venker CEO
    Planned sale
    $7.3M 200,000 shares at $36.31 17% of stake
    Traded Nov 3 Filed Nov 5
  5. Eric Venker CEO
    Planned sale
    $7.3M 200,000 shares at $36.59 14% of stake
    Traded Oct 28 Filed Oct 30
  6. Eric Venker CEO
    Planned sale
    $7M 200,000 shares at $35.11 13% of stake
    Traded Oct 20 Filed Oct 22
  7. Melissa B. Epperly Director
    Planned sale
    $641K 17,750 shares at $36.10 54% of stake
    Traded Oct 1 Filed Oct 5
  8. Eric Venker CEO
    Planned sale
    $7.3M 200,000 shares at $36.62 11% of stake
    Traded Sep 30 Filed Oct 2
  9. Melissa B. Epperly Director
    Planned sale
    $196K 4,938 shares at $39.74 33% of stake
    Traded Sep 15 Filed Sep 17
  10. Meghan Fitzgerald Director
    Planned sale
    $203K 5,112 shares at $39.74 12% of stake
    Traded Sep 15 Filed Sep 17
  11. Meghan Fitzgerald Director
    Planned sale
    $798K 20,000 shares at $39.90 32% of stake
    Traded Sep 8 Filed Sep 10
  12. Eric Venker CEO
    Planned sale
    $7.2M 200,000 shares at $35.77 11% of stake
    Traded Aug 28 Filed Sep 1
  13. Mayukh Sukhatme President & CIO
    Sale
    $12.4M 335,174 shares at $36.88 1.8% of stake
    Traded Aug 19–21 Filed Aug 21

Also filed in the last 12 months, not counted as buying or selling: 44 option exercises, 41 share withholdings for taxes, 38 other transactions, 21 stock grants, 2 sales to cover taxes, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 7 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 7.01,9.01
SCHEDULE 13D/A —
8-K 5.07,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf